11 Frequency at 10:00 am Optional n/a qualifier 12 Indication Optional Mandatory for medicines – prescribed required’ ‘when 13 Additional Optional n/a – instructions 14 Duration of for 10 days Optional n/a treatment for full course 15 N/A Mandatory for pack-based – prescribing 16 Supply N/A Mandatory for – prescribing n/a = not applicable Two active ingredients product Description Example Status Notes 1a 1st active ingredient perindopril Mandatory In bold arginine 2a Strength of 1st active 10 mg Mandatory for Described as quantity, ingredient pack-based non-breaking space and prescribing a unit of measure. Optional for dose-based prescribing 1b 2nd active ingredient amLODIPIne Mandatory In bold 2b Strength of 2nd active 10 mg Mandatory for As for first active ingredient pack-based ingredient prescribing 3 Brand name Optional Mandatory for dispense – according to display requirements in Section 6.1.3 4 Form tablet Optional n/a
11 Frequency qualifier at 10:00 am Optional n/a 12 Indication – Optional Mandatory for medicines prescribed ‘when required’ 13 Additional instructions – Optional n/a 14 Duration of treatment for full course for 10 days Optional n/a 15 – N/A Mandatory for pack-based prescribing 16 Supply – N/A Mandatory for prescribing n/a = not applicable Two active ingredients product Description Example Status Notes 1a 1st active ingredient perindopril arginine Mandatory In bold 2a Strength of 1st active ingredient 10 mg Mandatory for pack-based prescribing Described as quantity, non-breaking space and a unit of measure. Optional for dose-based prescribing 1b 2nd active ingredient amLODIPIne Mandatory In bold 2b Strength of 2nd active ingredient 10 mg Mandatory for pack-based prescribing As for first active ingredient 3 Brand name – Optional Mandatory for dispense according to display requirements in Section 6.1.3 4 Form tablet Optional n/a
National-Guidelines-for-On-Screen-Display-of-Consumer-Medicines-Information-Dec-2017.docx